WORLD Symposium Notebook: New Data In Lysosomal Diseases And A Push For Earlier Testing

The WORLD Symposium Feb. 13 to 16 in San Diego offered everything from basic research through late-stage clinical data in lysosomal diseases, including ArmaGen's blood-brain barrier-crossing treatment for Hurler syndrome and updates from ongoing development programs from rare disease specialists, such as Genzyme, Amicus and Protalix.

Hands

The WORLD Symposium from Feb. 13 to 16 in San Diego brought together academic researchers and biopharmaceutical companies to share emerging research in lysosomal diseases, including next-generation enzyme replacement therapies, gene therapies and tests that identify patients before debilitating effects of the diseases kick in.

Researchers, clinicians and biopharma company scientists presented a range of basic research, preclinical data and clinical trial results for Gaucher,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip